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Sclerotherapy of Peritoneal Inclusion
Cysts: Preliminary Results in Seven
Patients
Objective: To evaluate the technical feasibility and the clinical effectiveness of
sclerotherapy for the treatment of peritoneal inclusion cysts (PICs). 
Materials and Methods: Between June 1996 and February 2001, eight PICs in
seven female patients aged 28-43 (mean, 36) years were instilled with sclerosant
(povidone-iodine in three, ethanol in three, both povidone-iodine and ethanol in
one). All seven patients subsequently experienced less abdominal pain. After
drainage via an 8.5-Fr pigtail catheter inserted in the PICs (transabdominally in
six cases, transvaginally in one), sclerosant equivalent in volume to about one-
third that of drained fluid was introduced daily until the drained volume was less
than 5ml. Follow-up by means of clinical procedures and ultrasound was per-
formed every three months, at which time the success rate, possible complica-
tions and recurrence were determined. 
Results: Sclerotherapy was technically successful in all seven patients, though
immediately after the procedure, minor complications were noted in three patients
(mild pain in two, mild fever in one). During the follow-up of 4-60 (mean, 24.7)
months, sclerotherapy proved successful and without long-term complications in
all seven patients: lower abdominal pain disappeared and the diameter of the
cysts decreased more than 50%, with complete regression in four cases. During
the follow-up period there was no recurrence. 
Conclusion: Sclerotherapy following catheter insertion is technically feasible
and effective for the treatment of PICs.
eritoneal inlcusion cysts (PICs) have been referred to variously as peri-
toneal cysts, inflammatory cysts of the pelvic peritoneum, benign cystic
mesotheliomas, multilocular peritoneal cysts, ovarian pseudocysts, en-
trapped ovarian cysts, or a combination of these terms (1 4). Those that sometimes oc-
cur as a sequela of pelvic surgery, endometriosis or pelvic inflammatory disease consist
of a collection of localized peritoneal fluid (1, 5 12). 
Several published reports have described the successful radiologic diagnosis of PICs
(1, 6, 7, 9, 13 17), and a number of these have suggested that they may be treated
conservatively (1, 5 11, 15, 18). One such alternative to surgery is aspiration of the
fluid collection in order to relieve the acute symptoms (1, 7 9); another is hormonal
treatment using oral contraceptives (9, 18) or a gonadotropin-releasing hormone ago-
nist (10). Sclerotherapy has recently been used effectively and successfully in the treat-
ment of cysts of the kidney, liver, ovary and thyroid, and in the treatment of postoper-
ative lymphocele (19 23), but to our knowledge, few reports have described the appli-
cation of sclerotherapy to PICs (5).
The purpose of this study was to assess the technical feasibility and clinical effective-
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Pness of catheter drainage and sclerotherapy for the treat-
ment of PICs in a series of seven patients. 
MATERIALS AND METHODS
Between June 1996 and February 2001, seven female
patients referred by gynecologists underwent sclerothera-
py. The criteria for their selection were that they were
symptomatic and showed the radiologic features of PICs.
In all seven, sclerotherapy was indicated. All were pre-
menopausal and aged between 28 and 43 (mean, 36)
years. None were using oral contraceptives or other hor-
monal medications. All had a past medical history of pelvic
surgery, as detailed in Table 1, having undergone total ab-
dominal hysterectomy for uterine leiomyoma (n=3), cys-
tectomy and adhesiolysis due to previous tuberculosis
(n=2), leiomyomectomy of the uterus (n=1), or multiple
operations for traumatic intestinal rupture or PIC (n=1). A
diagnosis of PIC was established on the basis of clinical his-
tory and the imaging findings of ultrasound, CT, or MRI.
The mean time interval between previous surgery and di-
agnosis was 5.7 (range, 1 13) years. Tumor markers such
as CEA, AFP, CA125 and CA19-9 were checked at initial
diagnosis, and informed consent for sclerotherapy was ob-
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Fig. 1. A 37-year-old woman who underwent total abdominal hysterectomy for uterine leiomyoma ten years earlier presented with lower
abdominal pain (Patient 1).
A. Enhanced CT shows an elongated cystic mass with no solid component on the left side of the pelvis (arrows). 
B. Transabdominal ultrasonogram of the pelvis in the transverse plane indicates a persistent cystic mass with internal septation (arrow-
heads) after simple aspiration. The left ovary may be observed (arrow).
C. An 8.5-Fr pigtail catheter was introduced into the lesion transabdominally, and povidone-iodine was used for sclerotherapy.
D. Transvaginal ultrasonogram obtained 54 months after the procedure shows scanty fluid (arrows) around the left ovary (LO).
AB
CDtained from each patient.
We performed sclerotherapy in a total of eight PICs in
seven patients. The greatest diameter of each cyst was 6 13
(mean, 9.3) cm, and they were located in the pelvic cavity
(on the right side in two patients, on the left side in four,
and on both sides in one), sometimes with lower abdomi-
nal extension. In the angiographic unit, we initially inserted
an 8.5-Fr Ultrathane drainage catheter (Cook,
Bloomington, Ind., U.S.A.) using a 0.035-inch-diameter
Radiofocus M guide wire (Terumo, Tokyo, Japan) under
the guidance of ultrasound and/or fluoroscopy. Insertion
was transabdominal in seven cysts of six patients and
transvaginal in the remaining one cyst of one patient in
whom the transabdominal route was unsuitable due to
overlying small intestine. Immediately after draining as
much fluid as possible, a sclerosing agent was instilled and
the drained fluid was sent for cytologic examination. The
agent chosen was a 10% povidone-iodine topical solution
(SungKwang Pharm, Bucheon, Korea) in three patients,
absolute ethanol (J. T. Baker, Deventer, Holland) in three
others, and both povidone-iodine and ethanol in one. The
volume of sclerosing agent introduced was about one-third
of that of the drained fluid [20 50 (mean, 41) ml]. After the
sclerosant was injected into the cysts, patients were asked
to change their positions in order to bring the entire wall of
the cyst into contact with the sclerosant. The agent was
drained naturally after 15 minutes in the case of ethanol
and after one hour in the case of povidone-iodine. The
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Table 1. Sclerotherapy Data for Seven Female PIC Patients
Patient
PIC Sclerotherapy Follow-up
No. Age PMHx Sx Interval Size Amount
Color Cytology
Tumor
Route
Agent/ No. of
Cx
Duration
Sx
Size
Cx
(yr) (cm) (ml) marker Volume(ml) Installations (mo) (cm)
1 37 TAH Dark Mild
(Uterine LAP 10 8 170 brown N N TA P/50 3 pain 54 N 3 N
Leiomyoma)
2 29 Surgery Dark
(Bowel rupture, LAP 13 6 90 and N N TA P/30 2 N 60 N N N
Ovarian cyst) bloody
3 28 PIC LAP 1 13 330 Dark N N TA E/50 3 N 7 N 4 N
Cystectomy brown
(Tuberculous 12 380 Dark N N TA P/50 2 N 7 N N N
peritonitis) brown
4 39 TAH Dark
(Uterine LAP 3 9 500 yellow N N TA E/50 4 N 4 N 1.8 N
Leiomyoma)
5 43 TAH Dark Mild
(Uterine LAP 5 8.5 80 yellow N N TA E/30 3 pain 4 N N N
Leiomyoma)
6 39 Uterus Dark Mild
Myomectomy LAP 1 10 60 yellow N N TV E/20 3 fever 4 N N N
(Uterine
Leiomyoma)
7 38 PIC Clear
Cystectomy LAP 7 8 400 yellow N N TA P/50 5 N 40 N N N
(Tuberculous
peritonitis)
Note.─ *PMHX= past medical history, TAH=total abdominal hysterectomy
**Sx= symptom, LAP= lower abdominal pain
PIC= peritoneal inclusion cyst, Interval= time interval between previous surgery and the detection of PIC, N= negative
TA= transabdominal, TV= transvaginal, P= povidone-iodine, E= ethanol,
Volume= volume of sclerosant introduced at initial sclerotherapy, Cx= complication, N= negative
Sx= symptom, Cx= complication, N= negativeamount, color and odor of newly drained fluid, as well as
the position and patency of the catheters were checked
daily in all patients prior to further instillation of the scle-
rosant. The volume of the subsequently introduced scle-
rosant was also about one-third of the volume of newly
drained fluid. When less than 5ml was drained, the
catheter was removed and sclerotherapy ended.
If these successive procedures were completed, the over-
all procedure was regarded as technically feasible; if a pa-
tient’s symptoms improved and the diameter of a cyst de-
creased by more than 50%, the procedure was deemed
clinically successful. In each patient, subsequent follow-up
involved clinical and ultrasound examinations in the outpa-
tient clinic at three-month intervals. We analyzed the tech-
nical feasibility of sclerotherapy, the immediate success
rate, possible complications, and recurrence during the fol-
low-up period.
RESULTS
The patients’ primary diagnosis, previous surgical proce-
dures, records concerning sclerotherapy of PICs, and out-
comes, are summarized in Table 1. Sclerotherapy was tech-
nically successful and well tolerated in all patients and no
major procedural complications occurred (Figs. 1, 2). As
minor complications, mild abdominal pain in two patients
(patients 1 and 5) and mild fever in one (patient 6) were
noted immediately after the procedure and controlled ade-
quately with analgesics. The aspirated fluid specimens
were dark yellow (n=3), clear yellow (n=3), clear yellow
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Fig. 2. A 28-year-old woman who had taken anti-tuberculosis medication for tuberculous peritonitis seven years earlier presented with
lower abdominal pain (Patient 3).
A-C. T2-weighted (A), T1-weighted (B), and contrast-enhanced T1-weighted (C) MR images of the pelvis show a cystic mass 13cm in di-
ameter. On the right side of the huge cystic lesion, the intact left ovary (arrow) is noted; the right ovary (curved arrow) is normal.
D. Transvaginal ultrasonogram reveals a cystic mass encircling the left ovary (arrow), which is displaced to the right of the pelvis. (This
image was obtained transvaginally, and the ultrasonic probe is displayed at the top.)
AB
CD(n=1), or dark and bloody (n=1). Cytologic examination
revealed the presence of some mesothelial and inflamma-
tory cells, but no evidence of granulomatous inflammation
or malignancy, findings which are consistent with those of
earlier reports (3, 7, 9, 12). In two patients with a history
of tuberculosis (patients 3 and 7), there was no evidence of
either this or malignancy in the drained fluid. The scle-
rosant was instilled in each patient 2-5 (mean, 3.1) times.
During the follow-up period of 4-60 (mean, 24.7)
months, the symptoms of lower abdominal pain disap-
peared in all patients, and follow-up ultrasonography
showed that the diameter of all cystic lesions decreased by
more than 50%, disappearing completely in four patients
(57.1%) Neither long-term complications nor recurrence
were noted during the follow-up period. 
DISCUSSION
Because cystic lesions in the pelvic cavity are common in
postpubertal women (7), a cystic adnexal lesion prompts a
long list of differential diagnoses, including ovarian cancer
(5, 6). However, in premenopausal women with peritoneal
adhesions due to previous surgery, endometriosis or pelvic
inflammatory disease (2, 3, 6 8, 12, 18), PIC should be in-
cluded in the differential diagnosis (1, 2, 6 8). It has been
suggested, moreover, that these cysts are more common
than had been thought (1, 4, 7, 15, 16, 24). In our study, a
diagnosis of PIC was based on a patient’s previous PIC-re-
lated clinical and radiologic characteristics (1, 7 9, 13, 14).
Jain (1) asserted that if a lesion occurred outside the ovary,
and this was normal and ipsilateral, definitive diagnosis
was possible, and he summarized the imaging characteris-
tics of PIC as follows: entrapped ovary in a spider web pat-
tern, with peritoneal adhesions extending across the entire
width of a fluid collection, unlike hydrosalpinx and pyos-
alpinx, and intact normal ipsilateral ovary. In addition, the
values of tumor makers such as CEA, AFP, CA125 and
CA19-9 were normal in our patients, and aspirated fluid
cytology examination revealed no malignant cells. A PIC
frequently becomes multiple, and large enough to be
symptomatic (7). Pelvic pain or mass is usually a present-
ing feature (1 3, 6), and occurred in all seven of our pa-
tients. In addition, a PIC patient may be at risk of infertili-
ty, presumably due to scarring or the formation of adhe-
sions around the adnexa (7). The treatment of symptomatic
PIC is therefore essential, while for asymptomatic patients,
simple observation may suffice (5, 7). Only when these
cystic masses were shown by radiologic studies and labora-
tory data to be PICs, and the cause of pelvic pain, was scle-
rotherapy indicated.
Previously, PIC was treated mainly by surgical resection.
Gussman et al. (8) believed that surgery was the treatment
of choice and that percutaneous drainage was probably
helpful. Although the treatment of choice for PIC has not
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EF
E. An 8.5-Fr pigtail catheter was inserted transabdominally. Cytologic examination of the drained fluid, prior to sclerotherapy with ab-
solute ethanol, revealed no evidence of tuberculosis or malignancy.
F. Transabdominal ultrasonogram in transverse plane obtained seven months later shows a 4 cm-sized cyst with progressive reduction
in size (white arrow). The right ovary is also visible (open arrow).been firmly established, the consensus is that conservative
management is preferable to surgery (1, 5 11, 15, 18). The
reasons for this are as follows: first, PICs are pathologically
reactive, not neoplastic benign lesions (1 3, 6, 8, 10 12).
Histopathologically, the locules are lined by one or several
layers of flat, cuboidal mesothelial cells, which occasionally
form papillae (1). Even when the cuboidal cells undergo
squamous metaplasia, PICs have no malignant potential (1,
2). Second, because PICs adhere to the surface of the
ovary but do not involve the ovarian parenchyma, and
most patients are, moreover, premenopausal, oophorecto-
my is not recommended (3, 9). Third, after surgical resec-
tion, the recurrence rate is 30-50% (2). Fourth, PICs tend
to rupture frequently just after the abdomen is opened,
and resection is difficult because tissue planes are poorly
defined (8). Fifth, because most patients are symptomatic
and have previously undergone several laparotomies, addi-
tional surgical intervention is undesirable (1, 5).
Conservative alternatives to surgery include aspiration of
the collected fluid to relieve the acute symptoms (1, 7 9),
hormonal treatment using oral contraceptives (9, 18) and a
gonadotropin-releasing hormone agonist (10). Oral contra-
ceptives suppress ovulation, preventing accumulation by
decreased fluid production (1, 7). Additionally, Kurachi et
al (10) reported that after gonadotropin-releasing hormone
agonist treatment, PICs became smaller. They also indicat-
ed, however, that the therapeutic value of these hormonal
treatments might be limited in that their effect was short-
lived and they failed to resolve the adhered lesions (10,
11).
Previous reports have suggested that aspiration is a safe
and effective nonsurgical treatment for PICs (7, 8, 15, 17);
simple aspiration is, however, associated with a high recur-
rence rate (1 3, 5, 14, 25, 26), as in the aspiration of simple
renal cysts, hepatic cysts and postoperative lymphocele
(19, 20, 23). We therefore believe that sclerotherapy fol-
lowing drainage is essential for the treatment of PICs.
Kairuloma et al. (27) emphasized the need to bring the
sclerosant into contact with the entire mucosal surface of
the cyst, though since the majority of PICs have septations,
this may not be easy (6, 9, 14). These septations are some-
times related to recurrence after sclerotherapy, and we
therefore disrupted them by manipulating the guidewire
during the procedure.
Our study suffers from certain limitations. First, the num-
ber of patients involved was quite small, and subsequent
series should therefore involve more subjects. Second, be-
cause sclerotherapy was not performed in consecutive pa-
tients, but only in those who were referred, our evaluation
of its effectiveness in treating PICs may be limited. Third,
two different sclerosing agents were used, and we do not
know which was better. 
Because certain technical standards such as those relating
to the amount of sclerosant and the duration of sclerosant
instillation have not yet been established, the procedure
may vary according to the authors involved (5). Our meth-
ods rely, basically, on the techniques used in percutaneous
aspiration and sclerotherapy of lymphocele after surgery,
or in the treatment of renal cysts. For initial sclerotherapy
of PICs, we adopted the sclerotherapeutic method used for
lymphocele because both PICs and lymphocele share in
common the fact that they occur after pelvic surgery. At
that time, povidone-iodine was used for lymphocele, but
we replaced this with ethanol, which was effective in the
sclerotherapy of simple renal cysts and might enhance the
therapeutic effectiveness of sclerotherapy of PICs. Thus,
we used two kinds of sclerosing agent: povidone-iodine
and ethanol. Because our patients were few in number,
however, we were unable to compare their effectiveness. 
Although more extensive studies are needed, we believe
that our successful results, with no recurrence, are because
our approach involved intensive sclerotherapy until fluid
drainage was minimal. In our study, no serious complica-
tions such as viscus perforation, infection, bleeding, or the
spillage of cystic fluid and/or sclerosant into the peritoneal
cavity occurred during or after sclerotherapy, and the re-
sults are promising.
In conclusion, these preliminary results indicate that scle-
rotherapy following catheter insertion appears to be tech-
nically feasible and effective for the treatment of PICs.
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